药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Aluminium monostearate
Macitentan
The therapeutic efficacy of Macitentan can be decreased when used in combination with Dexibuprofen.
Aluminium monostearate
Ferulic acid
The therapeutic efficacy of Ferulic acid can be decreased when used in combination with Dexibuprofen.
Aluminium monostearate
Pinacidil
The therapeutic efficacy of Pinacidil can be decreased when used in combination with Dexibuprofen.
Aluminium monostearate
Nilvadipine
The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Dexibuprofen.
Aluminium monostearate
Diethylnorspermine
The therapeutic efficacy of Diethylnorspermine can be decreased when used in combination with Dexibuprofen.
Aluminium monostearate
Sitaxentan
The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Dexibuprofen.
Aluminium monostearate
Tienilic acid
The therapeutic efficacy of Tienilic acid can be decreased when used in combination with Dexibuprofen.
Aluminium monostearate
Pargyline
The therapeutic efficacy of Pargyline can be decreased when used in combination with Dexibuprofen.
Aluminium monostearate
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Dexibuprofen.
Aluminium monostearate
Sodium phosphate, monobasic
The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Dexibuprofen.
Aluminium monostearate
Tetrandrine
The risk or severity of hyperkalemia can be increased when Dexibuprofen is combined with Tetrandrine.
Aluminium monostearate
Lomerizine
The risk or severity of hyperkalemia can be increased when Dexibuprofen is combined with Lomerizine.
Aluminium monostearate
Emopamil
The risk or severity of hyperkalemia can be increased when Dexibuprofen is combined with Emopamil.
Aluminium monostearate
Dexverapamil
The risk or severity of hyperkalemia can be increased when Dexibuprofen is combined with Dexverapamil.
Aluminium monostearate
Fish oil
The risk or severity of hyperkalemia can be increased when Dexibuprofen is combined with Fish oil.
Aluminium monostearate
WIN 55212-2
The risk or severity of hyperkalemia can be increased when Dexibuprofen is combined with WIN 55212-2.
Aluminium monostearate
Caroverine
The risk or severity of hyperkalemia can be increased when Dexibuprofen is combined with Caroverine.
Aluminium monostearate
Penfluridol
The risk or severity of hyperkalemia can be increased when Dexibuprofen is combined with Penfluridol.
Aluminium monostearate
Lidoflazine
The risk or severity of hyperkalemia can be increased when Dexibuprofen is combined with Lidoflazine.
Aluminium monostearate
Terodiline
The risk or severity of hyperkalemia can be increased when Dexibuprofen is combined with Terodiline.